<description>Hello and welcome to the latest episode of OCTalks, the podcast series from Oncology Central. I am Jade Parker, Senior Editor of Oncology Central. 

Today I am joined by Leanne Bailey who is Branch Director of the Community Outreach Research and Engagement branch of the NCI’s Center to Reduce Cancer Health Disparities. 

In this interview, we will discuss contributing factors to early onset cancers, how are certain groups disproportionately affected and initiatives that are seeking to reduce disparities in cancer care. Thank you for joining us, LeeAnn.</description>

Hello and welcome to the latest episode of OCTalk…

Hello and welcome to the latest episode of OCTalks, the podcast series from Oncology Central. I am Jade Parker, Senior Editor of Oncology Central. 

Today I am joined by Leanne Bailey who is Branch Director of the Community Outreach Research and Engagement branch of the NCI’s Center to Reduce Cancer Health Disparities. 

In this interview, we will discuss contributing factors to early onset cancers, how are certain groups disproportionately affected and initiatives that are seeking to reduce disparities in cancer care. Thank you for joining us, LeeAnn.

Tackling the rise in early onset cancer: From research to health equity

<description>Trends, tools and transformation: the evolution of flow cytometry in bioanalysis by Taylor &amp; Francis Group</description>

Trends, tools and transformation: the evolution o…

Trends, tools and transformation: the evolution of flow cytometry in bioanalysis by Taylor & Francis Group

Trends, tools and transformation: the evolution of flow cytometry in bioanalysis

<description>115 analytes, one panel: a conversation on innovation in biomarker discovery by Taylor &amp; Francis Group</description>

115 analytes, one panel: a conversation on innova…

115 analytes, one panel: a conversation on innovation in biomarker discovery by Taylor & Francis Group

115 analytes, one panel: a conversation on innovation in biomarker discovery

<description>Exploring biomarker testing in clinical research</description>

Exploring biomarker testing in clinical research

<description>Join Tara Crawford-Parks, PhD, Director for Translational R&amp;D and Product Enablement at DNA Genotek, to explore the potential of first void urine biomarkers in clinical diagnostics. Discover how this non-invasive sampling method is transforming HPV screening and opening new possibilities for early disease detection in oncology and infectious diseases. Learn about the science behind first void urine collection, its advantages over traditional sampling methods, and how innovative devices like the Colli-Pee™ are supporting more accessible healthcare for underserved populations worldwide.</description>

Join Tara Crawford-Parks, PhD, Director for Trans…

Join Tara Crawford-Parks, PhD, Director for Translational R&D and Product Enablement at DNA Genotek, to explore the potential of first void urine biomarkers in clinical diagnostics. Discover how this non-invasive sampling method is transforming HPV screening and opening new possibilities for early disease detection in oncology and infectious diseases. Learn about the science behind first void urine collection, its advantages over traditional sampling methods, and how innovative devices like the Colli-Pee™ are supporting more accessible healthcare for underserved populations worldwide.

Future Science Group

Details

Recent Episodes